Ownership

Edward T. Mathers

Insider Reports History

Entity: Individual
Location: C/O Medimmune, Inc., One Medimmune Way, Gaithersburg, MD
Signature: /s/ Zachary Bambach, attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edward T. Mathers:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Monte Rosa Therapeutics, Inc.	10%+ Owner	Common Stock	7.69M	$146M	$19.00	Jun 28, 2021	Indirect
Savara Inc	10%+ Owner	Common Stock	24.5M	$109M	$4.45	Jul 17, 2023	Indirect
Korro Bio, Inc.	10%+ Owner	Common Stock	1.09M	$61.1M	$56.00	Apr 22, 2024	Indirect
MBX Biosciences, Inc.	Director, 10%+ Owner	Common Stock	3.61M	$38.6M	$10.69	Sep 16, 2024	Indirect
RHYTHM PHARMACEUTICALS, INC.	Director	Common Stock	5.77K	$226K	$39.10	Jun 21, 2024	Indirect
RHYTHM PHARMACEUTICALS, INC.	Director	Common Stock	3K	$117K	$39.10	Jun 21, 2024	Direct
RHYTHM PHARMACEUTICALS, INC.	Director	Restricted Stock Units	0	$0	$39.10	Jun 21, 2024	Direct
NeueHealth, Inc.	10%+ Owner	Warrant (Right to Buy)	557K			Oct 1, 2024	Indirect
Senti Biosciences, Inc.	Director	Stock Option (Right to Buy)	43.9K			Mar 7, 2025	Direct
SYNLOGIC, INC.	Director	Stock Option (right to buy)	30K			Jun 22, 2023	Direct
Trevi Therapeutics, Inc.	Director	Nonstatutory Stock Option (right to buy)	30K			Jun 13, 2024	Direct
Inozyme Pharma, Inc.	Director	Stock Option (right to buy)	28K			Jun 18, 2024	Direct
Mirum Pharmaceuticals, Inc.	Director	Stock Option (right to buy)	17K			Jun 2, 2022	Direct
MBX Biosciences, Inc.	Director, 10%+ Owner	Stock Option (Right to Buy)	16K			Sep 12, 2024	Direct
Reneo Pharmaceuticals, Inc.	Director	Stock Option (right to buy)	15.3K			Oct 4, 2024	Direct
RHYTHM PHARMACEUTICALS, INC.	Director	Stock Option (right to buy)	14K			Jun 18, 2024	Direct
OnKure Therapeutics, Inc.	Director	Class A Common Stock	2.58K			Mar 31, 2025	Direct
Akouos, Inc.	Director	Stock Option (right to buy)	0			Dec 1, 2022	Direct
MBX Biosciences, Inc.	Director, 10%+ Owner	Series A Convertible Preferred Stock	0			Sep 16, 2024	Indirect
MBX Biosciences, Inc.	Director, 10%+ Owner	Series B Convertible Preferred Stock	0			Sep 16, 2024	Indirect
Monte Rosa Therapeutics, Inc.	10%+ Owner	Series A-2 convertible preferred stock	0			Jun 28, 2021	Indirect
Monte Rosa Therapeutics, Inc.	10%+ Owner	Series B convertible preferred stock	0		$2.00	Jun 28, 2021	Indirect
Monte Rosa Therapeutics, Inc.	10%+ Owner	Series C convertible preferred Stock	0			Jun 28, 2021	Indirect

Previous1Next

Showing 1 to 23 of 23 entries

Insider Reports Filed by Edward T. Mathers

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
OKUR	OnKure Therapeutics, Inc.	Mar 31, 2025	1	$0	4	Apr 2, 2025	Director
SNTI	Senti Biosciences, Inc.	Mar 7, 2025	1	$0	4	Mar 11, 2025	Director
OKUR	OnKure Therapeutics, Inc.	Oct 4, 2024	1	$0	4	Oct 8, 2024	Director
NEUE	NeueHealth, Inc.	Oct 1, 2024	2	$0	4	Oct 3, 2024	10%+ Owner
MBX	MBX Biosciences, Inc.	Sep 16, 2024	5	$8M	4	Sep 17, 2024	Director, 10%+ Owner
MBX	MBX Biosciences, Inc.	Sep 12, 2024	1	$0	4	Sep 13, 2024	Director, 10%+ Owner
MBX	MBX Biosciences, Inc.	Sep 12, 2024	0	$0	3	Sep 12, 2024	Director, 10%+ Owner
SNTI	Senti Biosciences, Inc.	Jul 10, 2024	1	$0	4	Jul 12, 2024	Director
RYTM	RHYTHM PHARMACEUTICALS, INC.	Jun 21, 2024	2	$0	4	Jun 25, 2024	Director
RYTM	RHYTHM PHARMACEUTICALS, INC.	Jun 18, 2024	2	$0	4	Jun 20, 2024	Director
INZY	Inozyme Pharma, Inc.	Jun 18, 2024	1	$0	4	Jun 20, 2024	Director
TRVI	Trevi Therapeutics, Inc.	Jun 13, 2024	1	$0	4	Jun 14, 2024	Director
KRRO	Korro Bio, Inc.	Apr 22, 2024	1	$1M	4	Apr 24, 2024	10%+ Owner
NEUE	NeueHealth, Inc.	Apr 8, 2024	2	$0	4	Apr 10, 2024	10%+ Owner
BHG	Bright Health Group Inc.	Dec 19, 2023	1	$0	4	Dec 21, 2023	10%+ Owner
FREQ	Korro Bio, Inc.	Nov 3, 2023	0	$0	3	Nov 7, 2023	10%+ Owner
BHG	Bright Health Group Inc.	Oct 31, 2023	1	$0	4	Nov 2, 2023	10%+ Owner
BHG	Bright Health Group Inc.	Sep 15, 2023	1	$0	4	Sep 19, 2023	10%+ Owner
BHG	Bright Health Group Inc.	Aug 11, 2023	1	$0	4	Aug 15, 2023	10%+ Owner
SVRA	Savara Inc	Jul 17, 2023	1	$1M	4	Jul 19, 2023	10%+ Owner
TRVI	Trevi Therapeutics, Inc.	Jun 28, 2023	1	$0	4	Jun 30, 2023	Director
SYBX	SYNLOGIC, INC.	Jun 22, 2023	1	$0	4	Jun 26, 2023	Director
RYTM	RHYTHM PHARMACEUTICALS, INC.	Jun 21, 2023	2	$0	4	Jun 23, 2023	Director
SNTI	Senti Biosciences, Inc.	Jun 16, 2023	1	$0	4	Jun 21, 2023	Director
INZY	Inozyme Pharma, Inc.	Jun 13, 2023	1	$0	4	Jun 15, 2023	Director
RPHM	Reneo Pharmaceuticals, Inc.	Jun 6, 2023	1	$0	4	Jun 8, 2023	Director
RYTM	RHYTHM PHARMACEUTICALS, INC.	Mar 2, 2023	1	$0	4	Mar 6, 2023	Director
OBSV	ObsEva SA	Jan 1, 2023	0	$0	3	Jan 3, 2023	Director
AKUS	Akouos, Inc.	Dec 1, 2022	1	$0	4	Dec 2, 2022	Director
BHG	Bright Health Group Inc.	Oct 17, 2022	2	$138M	4	Oct 19, 2022	10%+ Owner
SNTI	Senti Biosciences, Inc.	Jul 13, 2022	1	$0	4	Jul 15, 2022	Director
AKUS	Akouos, Inc.	Jun 23, 2022	1	$0	4	Jun 27, 2022	Director
TRVI	Trevi Therapeutics, Inc.	Jun 23, 2022	1	$0	4	Jun 23, 2022	Director
INZY	Inozyme Pharma, Inc.	Jun 10, 2022	1	$0	4	Jun 14, 2022	Director
SYBX	SYNLOGIC, INC.	Jun 9, 2022	1	$0	4	Jun 13, 2022	Director
SNTI	Senti Biosciences, Inc.\	Jun 8, 2022	0	$0	3	Jun 15, 2022	Director
RYTM	RHYTHM PHARMACEUTICALS, INC.	Jun 8, 2022	1	$0	4	Jun 10, 2022	Director
MIRM	Mirum Pharmaceuticals, Inc.	Jun 2, 2022	1	$0	4	Jun 6, 2022	Director
RPHM	Reneo Pharmaceuticals, Inc.	Jun 1, 2022	1	$0	4	Jun 3, 2022	Director
TRVI	Trevi Therapeutics, Inc.	Apr 11, 2022	2	$7.5M	4	Apr 13, 2022	Director
BHG	Bright Health Group Inc.	Jan 3, 2022	0	$0	3	Jan 5, 2022	10%+ Owner
GLUE	Monte Rosa Therapeutics, Inc.	Jun 28, 2021	7	$20M	4	Jun 30, 2021	10%+ Owner
AKUS	Akouos, Inc.	Jun 24, 2021	1	$0	4	Jun 25, 2021	Director
BHG	Bright Health Group Inc.	Jun 24, 2021	0	$0	3	Jun 24, 2021	10%+ Owner
INZY	Inozyme Pharma, Inc.	Jun 23, 2021	1	$0	4	Jun 24, 2021	Director
GLUE	Monte Rosa Therapeutics, Inc.	Jun 23, 2021	0	$0	3	Jun 23, 2021	10%+ Owner
TRVI	Trevi Therapeutics, Inc.	Jun 16, 2021	1	$0	4	Jun 17, 2021	Director
SYBX	SYNLOGIC, INC.	Jun 10, 2021	1	$0	4	Jun 14, 2021	Director
RYTM	RHYTHM PHARMACEUTICALS, INC.	Jun 9, 2021	1	$0	4/A	Jun 16, 2021	Director
MIRM	Mirum Pharmaceuticals, Inc.	Jun 4, 2021	1	$0	4	Jun 8, 2021	Director
RYTM	RHYTHM PHARMACEUTICALS, INC.	Jun 9, 2011	1	$0	4	Jun 11, 2021	Director